{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:00:21Z","timestamp":1790650821683,"version":"4.1.0"},"reference-count":40,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Many proteins integral to psychotropic agents\u2019 pharmacokinetics (PK) and pharmacodynamics (PD) exhibit circadian variation in expression and function. Chronopharmacology examines the effect of circadian systems on the pharmacology of drugs. Herein, we review the impact of circadian rhythm on drug-metabolizing enzymes and target receptors, with implications for the chronopharmacology of anticonvulsants, antidepressants, and antipsychotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Systematic searches of MEDLINE, Embase, PsycINFO, AMED, and JBI EBP were conducted from inception to September 2025 using terms related to \u201ccircadian rhythm,\u201d \u201cchronopharmacology,\u201d and \u201cpsychotropic agents.\u201d Preclinical and clinical studies investigating circadian-aligned dosing effects on anticonvulsant, antidepressant, or antipsychotic PK\/PD were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eight preclinical and one clinical study met inclusion criteria. Preliminary evidence suggests that circadian timing may influence the pharmacology of select psychotropic agents. Circadian timing influenced valproic acid PK and antiseizure activity in preclinical seizure models, whereas the single clinical study demonstrated differences in serum valproate concentrations but not seizure outcomes. For antidepressants (i.e., imipramine, milnacipran, fluoxetine, venlafaxine, bupropion), dose-timing altered monoaminergic PD measures in preclinical studies, although the relationship between these findings and antidepressant efficacy remains uncertain. Limited evidence suggests that circadian timing may influence the metabolic effects of quetiapine in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Current evidence provides preliminary support that circadian rhythm may differentially affect the pharmacology of select psychotropic agents. Whether the foregoing translates into clinically meaningful differences in efficacy, tolerability, and\/or posology of the evaluated agents\/classes requires systematic evaluation. Given that evidence is predominantly preclinical, further studies using clinically relevant repeated-dose regimens and disease-relevant animal models are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811261488466","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:16:36Z","timestamp":1790338596000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronopharmacology and implications for the safety and efficacy of anticonvulsants, antipsychotics, and antidepressants: A systematic review"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6419-8382","authenticated-orcid":false,"given":"Victoria Yue","family":"Tan","sequence":"first","affiliation":[{"name":"Brain and Cognition Discovery Foundation, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Wong","sequence":"additional","affiliation":[{"name":"Brain and Cognition Discovery Foundation, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia Han","family":"Le","sequence":"additional","affiliation":[{"name":"Brain and Cognition Discovery Foundation, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela T. H.","family":"Kwan","sequence":"additional","affiliation":[{"name":"Brain and Cognition Discovery Foundation, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie C.","family":"Zhang","sequence":"additional","affiliation":[{"name":"University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Jing","family":"Zheng","sequence":"additional","affiliation":[{"name":"Brain and Cognition Discovery Foundation, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Teopiz","sequence":"additional","affiliation":[{"name":"Brain and Cognition Discovery Foundation, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Dri","sequence":"additional","affiliation":[{"name":"Brain and Cognition Discovery Foundation, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Ho","sequence":"additional","affiliation":[{"name":"National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-0647","authenticated-orcid":false,"given":"Stavroula","family":"Bargiota","sequence":"additional","affiliation":[{"name":"University of Thessaly, Volos, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[{"name":"Southwest University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"University of Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","unstructured":"Aleksandrova LR Phillips AG (2021) Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends in Pharmacological Sciences 42(11): 929\u2013942. https:\/\/doi.org\/10.1016\/j.tips.2021.08.003","DOI":"10.1016\/j.tips.2021.08.003"},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","unstructured":"Allada R Bass J (2021) Circadian mechanisms in medicine. The New England Journal of Medicine 384(6): 550\u2013561. https:\/\/doi.org\/10.1056\/NEJMra1802337","DOI":"10.1056\/NEJMra1802337"},{"key":"e_1_3_4_4_1","doi-asserted-by":"crossref","unstructured":"Ben-Cherif W Dridi I Aouam K et al. (2012) Chronotolerance study of the antiepileptic drug valproic acid in mice. Journal of Circadian Rhythms 10: 3. https:\/\/doi.org\/10.1186\/1740-3391-10-3","DOI":"10.1186\/1740-3391-10-3"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","unstructured":"Ben-Cherif W Dridi I Aouam K et al. (2013) Circadian variation of Valproic acid pharmacokinetics in mice. European Journal of Pharmaceutical Sciences 49(4): 468\u2013473. https:\/\/doi.org\/10.1016\/j.ejps.2013.05.009","DOI":"10.1016\/j.ejps.2013.05.009"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","unstructured":"Colita C-I Hermann DM Filfan M et al. (2024) Optimizing chronotherapy in psychiatric care: The impact of Circadian rhythms on medication timing and efficacy. Clocks & Sleep 6(4): 635\u2013655. https:\/\/doi.org\/10.3390\/clockssleep6040043","DOI":"10.3390\/clockssleep6040043"},{"key":"e_1_3_4_7_1","unstructured":"Covidence (2025) Better Systematic Review Management. Covidence. https:\/\/www.covidence.org"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","unstructured":"Dallmann R Okyar A L\u00e9vi F (2016) Dosing-time makes the poison: Circadian regulation and pharmacotherapy. Trends in Molecular Medicine 22(5): 430\u2013445. https:\/\/doi.org\/10.1016\/j.molmed.2016.03.004","DOI":"10.1016\/j.molmed.2016.03.004"},{"key":"e_1_3_4_9_1","doi-asserted-by":"crossref","unstructured":"De Pieri M (2025) Strategic and tactic use of antipsychotic medications in schizophrenia: A perspective on current prescription practice. Discover Mental Health 5(1): 145. https:\/\/doi.org\/10.1007\/s44192-025-00283-6","DOI":"10.1007\/s44192-025-00283-6"},{"key":"e_1_3_4_10_1","doi-asserted-by":"crossref","unstructured":"Fujimura A Ushijima K (2023) Understanding the role of chronopharmacology for drug optimization: What do we know? Expert Review of Clinical Pharmacology 16(7): 655\u2013668. https:\/\/doi.org\/10.1080\/17512433.2023.2233438","DOI":"10.1080\/17512433.2023.2233438"},{"key":"e_1_3_4_11_1","doi-asserted-by":"crossref","unstructured":"Graf W Fraunberger B Yang T et al. (2009) Once daily monotherapy with prolonged-release valproate minitablets given in the evening\u2014A chronopharmacological study. International Journal of Clinical Pharmacology and Therapeutics 47(7): 439\u2013443. https:\/\/doi.org\/10.5414\/cpp47439","DOI":"10.5414\/CPP47439"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43"},{"key":"e_1_3_4_13_1","doi-asserted-by":"crossref","unstructured":"Johansson A Brask J Owe-Larsson B et al. (2011) Valproic acid phase shifts the rhythmic expression of PERIOD2::LUCIFERASE. Journal of Biological Rhythms 26(6): 541\u2013551. https:\/\/doi.org\/10.1177\/0748730411419775","DOI":"10.1177\/0748730411419775"},{"key":"e_1_3_4_14_1","doi-asserted-by":"crossref","unstructured":"Kapse S Ando H Fujiwara Y et al. (2017) Effect of a dosing-time on quetiapine-induced acute hyperglycemia in mice. Journal of Pharmacological Sciences 133(3): 139\u2013145. https:\/\/doi.org\/10.1016\/j.jphs.2017.02.008","DOI":"10.1016\/j.jphs.2017.02.008"},{"key":"e_1_3_4_15_1","doi-asserted-by":"crossref","unstructured":"Ka\u015fkal M Sevim M \u00dclker G et al (2025) The clinical impact of chronopharmacology on current medicine. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology 398(6): 6179\u20136191. https:\/\/doi.org\/10.1007\/s00210-025-03788-7","DOI":"10.1007\/s00210-025-03788-7"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","unstructured":"Kawai H Iwadate R Ishibashi T et al. (2019) Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice. Chronobiology International 36(9): 1194\u20131207. https:\/\/doi.org\/10.1080\/07420528.2019.1625360","DOI":"10.1080\/07420528.2019.1625360"},{"key":"e_1_3_4_17_1","doi-asserted-by":"crossref","unstructured":"Kawai H Kodaira N Tanaka C et al. (2018a). Time of administration of acute or chronic doses of imipramine affects its antidepressant action in rats. Journal of Circadian Rhythms 16: 5. https:\/\/doi.org\/10.5334\/jcr.156","DOI":"10.5334\/jcr.156"},{"key":"e_1_3_4_18_1","doi-asserted-by":"crossref","unstructured":"Kawai H Machida M Ishibashi T et al. (2018b). Chronopharmacological analysis of antidepressant activity of a dual-action serotonin noradrenaline reuptake inhibitor (SNRI) milnacipran in rats. Biological and Pharmaceutical Bulletin 41(2): 213\u2013219. https:\/\/doi.org\/10.1248\/bpb.b17-00733","DOI":"10.1248\/bpb.b17-00733"},{"key":"e_1_3_4_19_1","doi-asserted-by":"crossref","unstructured":"Keller J Gomez R Williams G et al. (2017) HPA axis in major depression: Cortisol clinical symptomatology and genetic variation predict cognition. Molecular Psychiatry 22(4): 527\u2013536. https:\/\/doi.org\/10.1038\/mp.2016.120","DOI":"10.1038\/mp.2016.120"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","unstructured":"Khedhaier WBC Dridi I Aouam K et al. (2017) Circadian variation in anticonvulsant activity of valproic acid in mice. Biomedicine and Pharmacotherapy 95: 25EP\u201330EP. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.047","DOI":"10.1016\/j.biopha.2017.08.047"},{"key":"e_1_3_4_21_1","doi-asserted-by":"crossref","unstructured":"Koch CE Leinweber B Drengberg BC et al. (2016) Interaction between circadian rhythms and stress. Neurobiology Stress 6: 57\u201367. https:\/\/doi.org\/10.1016\/j.ynstr.2016.09.001","DOI":"10.1016\/j.ynstr.2016.09.001"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","unstructured":"McIntyre RS Alda M Baldessarini RJ et al. (2022) The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry 21(3): 364\u2013387. https:\/\/doi.org\/10.1002\/wps.20997","DOI":"10.1002\/wps.20997"},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","unstructured":"McIntyre RS Alsuwaidan M Baune BT et al. (2023) Treatment-resistant depression: Definition prevalence detection management and investigational interventions. World Psychiatry 22(3): 394\u2013412. https:\/\/doi.org\/10.1002\/wps.21120","DOI":"10.1002\/wps.21120"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","unstructured":"McIntyre RS Berk M Brietzke E et al. (2020) Bipolar disorders. Lancet 396(10265): 1841\u20131856. https:\/\/doi.org\/10.1016\/S0140-6736(20)31544-0","DOI":"10.1016\/S0140-6736(20)31544-0"},{"key":"e_1_3_4_25_1","first-page":"3","article-title":"Atypical antipsychotics: Sleep, sedation, and efficacy","volume":"6","author":"Miller DD","year":"2004","unstructured":"Miller DD (2004) Atypical antipsychotics: Sleep, sedation, and efficacy. Primary Care Companion to the Journal of Clinical Psychiatry 6(Suppl 2): 3\u20137.","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","unstructured":"Murrough JW Abdallah CG Mathew SJ. (2017) Targeting glutamate signalling in depression: Progress and prospects. Nature Reviews Drug Discovery 16(7): 472\u2013486. https:\/\/doi.org\/10.1038\/nrd.2017.16","DOI":"10.1038\/nrd.2017.16"},{"key":"e_1_3_4_27_1","doi-asserted-by":"crossref","unstructured":"Nader N Chrousos GP Kino T (2010) Interactions of the circadian CLOCK system and the HPA axis. Trends in Endocrinology & Metabolism 21(5): 277\u2013286. https:\/\/doi.org\/10.1016\/j.tem.2009.12.011","DOI":"10.1016\/j.tem.2009.12.011"},{"key":"e_1_3_4_28_1","doi-asserted-by":"crossref","unstructured":"Naesgaard JAR Gjerstad L Heuser K et al. (2023) Biological rhythms and epilepsy treatment. Frontiers in Neurology 14: 1153975. https:\/\/doi.org\/10.3389\/fneur.2023.1153975","DOI":"10.3389\/fneur.2023.1153975"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","unstructured":"Nagayama H (1999) Influences of biological rhythms on the effects of psychotropic drugs. Psychosomatic Medicine 61(5): 618\u2013629. https:\/\/doi.org\/10.1097\/00006842-199909000-00006","DOI":"10.1097\/00006842-199909000-00006"},{"key":"e_1_3_4_30_1","doi-asserted-by":"crossref","unstructured":"Nutt DJ Blier P (2016) Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology. Journal of Psychopharmacology 30(5): 413\u2013415. https:\/\/doi.org\/10.1177\/0269881116642903","DOI":"10.1177\/0269881116642903"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","unstructured":"Page MJ McKenzie JE Bossuyt PM et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.) 372: n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_4_32_1","doi-asserted-by":"crossref","unstructured":"Pareek M Johansen ND Christensen SH et al. (2025) Trials on timing of cardiovascular medication administration: The Cardiovascular Circadian Chronotherapy Trial Concept. JACC: Advances 4(10 Pt 2): 102147. https:\/\/doi.org\/10.1016\/j.jacadv.2025.102147","DOI":"10.1016\/j.jacadv.2025.102147"},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","unstructured":"Rabl U Bartova L Sezen P et al. (2025) HPA axis in psychotic and non-psychotic major depression: Cortisol plasma levels and hippocampal volume. Journal of Affective Disorders 377: 14\u201322. https:\/\/doi.org\/10.1016\/j.jad.2025.02.014","DOI":"10.1016\/j.jad.2025.02.014"},{"key":"e_1_3_4_34_1","volume-title":"Valproic Acid","author":"Rahman M","year":"2025","unstructured":"Rahman M, Awosika AO, Nguyen H. (2025) Valproic Acid. StatPearls Publishing."},{"key":"e_1_3_4_35_1","doi-asserted-by":"crossref","unstructured":"Ramgopal S Thome-Souza S Loddenkemper T (2013) Chronopharmacology of anti-convulsive therapy. Current Neurology and Neuroscience Reports 13(4): 339. https:\/\/doi.org\/10.1007\/s11910-013-0339-2","DOI":"10.1007\/s11910-013-0339-2"},{"key":"e_1_3_4_36_1","doi-asserted-by":"crossref","unstructured":"Samanta S Bagchi D (2024) An intricate relationship between circadian rhythm dysfunction and psychiatric diseases. Exploration of Neuroscience 3: 321\u201351. https:\/\/doi.org\/10.37349\/en.2024.00053","DOI":"10.37349\/en.2024.00053"},{"key":"e_1_3_4_37_1","doi-asserted-by":"crossref","unstructured":"Silva S Bicker J Falcao A et al. (2021) Antidepressants and circadian rhythm: Exploring their bidirectional interaction for the treatment of depression. Pharmaceutics 13(11): 1975. https:\/\/doi.org\/10.3390\/pharmaceutics13111975","DOI":"10.3390\/pharmaceutics13111975"},{"key":"e_1_3_4_38_1","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. (2016) ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355: i4919.","journal-title":"BMJ"},{"key":"e_1_3_4_39_1","doi-asserted-by":"crossref","unstructured":"Varghese FP Brown ES (2001) The hypothalamic-pituitary-adrenal axis in major depressive disorder: A brief primer for primary care physicians. Primary Care Companion to the Journal of Clinical Psychiatry 3(4): 151\u2013155. https:\/\/doi.org\/10.4088\/pcc.v03n0401","DOI":"10.4088\/PCC.v03n0401"},{"key":"e_1_3_4_40_1","doi-asserted-by":"crossref","unstructured":"Walker WH Walton JC DeVries AC et al. (2020) Circadian rhythm disruption and mental health. Translational Psychiatry 10: 28. https:\/\/doi.org\/10.1038\/s41398-020-0694-0","DOI":"10.1038\/s41398-020-0694-0"},{"key":"e_1_3_4_41_1","doi-asserted-by":"crossref","unstructured":"Ye R Yang X Zhang X et al. (2025) Morning vs bedtime dosing and nocturnal blood pressure reduction in patients with hypertension: The OMAN Randomized Clinical Trial. JAMA Network Open 8(7): e2519354. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.19354","DOI":"10.1001\/jamanetworkopen.2025.19354"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811261488466","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811261488466","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811261488466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:47:15Z","timestamp":1790650035000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811261488466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":40,"alternative-id":["10.1177\/02698811261488466"],"URL":"https:\/\/doi.org\/10.1177\/02698811261488466","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"02698811261488466"}}